Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

May 2018
1. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
   Effect of Tissue Factor on Colorectal Cancer Stem Cells.
   Anticancer Res. 2018;38:2635-2642.
   PubMed     Text format     Abstract available
   
   
   
2. NASSEREDDINE S, Alsubait S, Tabbara I
   Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
   Anticancer Res. 2018;38:2597-2605.
   PubMed     Text format     Abstract available
   
   
   
3. KAWAMOTO M, Umebayashi M, Tanaka H, Koya N, et al
   Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
   Anticancer Res. 2018;38:2739-2748.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. TERASAKI M, Ogawa Y, Endo T, Maeda H, et al
   Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
   Anticancer Res. 2018;38:2169-2179.
   PubMed     Text format     Abstract available
   
   
   
5. SANTORO R, Zanotto M, Carbone C, Piro G, et al
   MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
   Anticancer Res. 2018;38:1937-1946.
   PubMed     Text format     Abstract available
   
   
   March 2018
6. KANEKO S, Sato C, Shiozawa N, Sato A, et al
   Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
   Anticancer Res. 2018;38:1391-1399.
   PubMed     Text format     Abstract available
   
   
   February 2018
7. KANG S, Oh SC, Min BW, Lee DH, et al
   Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
   Anticancer Res. 2018;38:787-794.
   PubMed     Text format     Abstract available
   
   
   January 2018
8. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
   The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
   Anticancer Res. 2018;38:313-320.
   PubMed     Text format     Abstract available
   
   
   
9. LAPINSKA K, Faria G, McGonagle S, Macumber KM, et al
   Cancer Progenitor Cells: The Result of an Epigenetic Event?
   Anticancer Res. 2018;38:1-6.
   PubMed     Text format     Abstract available
   
   
   November 2017
10. SANOMACHI T, Suzuki S, Kuramoto K, Takeda H, et al
    Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Anticancer Res. 2017;37:6177-6188.
    PubMed     Text format     Abstract available
    
    
    October 2017
11. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available
    
    
    
12. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Text format     Abstract available
    
    
    September 2017
13. SAKABE T, Azumi J, Umekita Y, Toriguchi K, et al
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:4881-4888.
    PubMed     Text format     Abstract available
    
    
    
14. JUNGBAUER F, Aderhold C, Birk R, Hoermann K, et al
    Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1alpha.
    Anticancer Res. 2017;37:4827-4836.
    PubMed     Text format     Abstract available
    
    
    
15. GOMES JPA, Assoni AF, Pelatti M, Coatti G, et al
    Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Anticancer Res. 2017;37:4747-4758.
    PubMed     Text format     Abstract available
    
    
    August 2017
16. URUSHIBARA S, Tsubota T, Asai R, Azumi J, et al
    WNT/beta-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
    Anticancer Res. 2017;37:4085-4091.
    PubMed     Text format     Abstract available
    
    
    
17. LI Y, Wu J, Feng F, Men C, et al
    A Preclinical Study of Cell-seeded Tubularized Scaffolds Specially Secreting LL37 for Reconstruction of Long Urethral Defects.
    Anticancer Res. 2017;37:4295-4301.
    PubMed     Text format     Abstract available
    
    
    July 2017
18. SETO K, Sakabe T, Itaba N, Azumi J, et al
    A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Anticancer Res. 2017;37:3569-3579.
    PubMed     Text format     Abstract available
    
    
    
19. HAYASHI T, Yamashita T, Okada H, Oishi N, et al
    A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3397-3403.
    PubMed     Text format     Abstract available
    
    
    
20. PAN XY, Tsai MH, Wuputra K, Ku CC, et al
    Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
    Anticancer Res. 2017;37:3367-3377.
    PubMed     Text format     Abstract available
    
    
    June 2017
21. ERCAN G, Karlitepe A, Ozpolat B
    Pancreatic Cancer Stem Cells and Therapeutic Approaches.
    Anticancer Res. 2017;37:2761-2775.
    PubMed     Text format     Abstract available
    
    
    May 2017
22. MIYATA T, Oyama T, Yoshimatsu T, Higa H, et al
    The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
    Anticancer Res. 2017;37:2541-2547.
    PubMed     Text format     Abstract available
    
    
    
23. DA CRUZ PAULA A, Lopes C
    Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.
    Anticancer Res. 2017;37:2173-2183.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. STOTZ M, Herzog SA, Pichler M, Smolle M, et al
    Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Anticancer Res. 2017;37:2011-2018.
    PubMed     Text format     Abstract available
    
    
    
25. BRADY PC, Soiffer RJ, Ginsburg ES
    Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report.
    Anticancer Res. 2017;37:1985-1987.
    PubMed     Text format     Abstract available
    
    
    
26. DAS T, Nair RR, Green R, Padhee S, et al
    Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Anticancer Res. 2017;37:1655-1663.
    PubMed     Text format     Abstract available
    
    
    
27. NASSEREDDINE S, Rafei H, Elbahesh E, Tabbara I, et al
    Acute Graft Versus Host Disease: A Comprehensive Review.
    Anticancer Res. 2017;37:1547-1555.
    PubMed     Text format     Abstract available
    
    
    
28. OKU Y, Nishiya N, Tsuda K, Shibazaki M, et al
    Dynamic Phenotypic Transition of Breast Cancer Cells In Vitro Revealed by Self-floating Cell Culture.
    Anticancer Res. 2017;37:1793-1797.
    PubMed     Text format     Abstract available
    
    
    March 2017
29. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Text format     Abstract available
    
    
    February 2017
30. SIRIMANGKALAKITTI N, Chamni S, Suwanborirux K, Chanvorachote P, et al
    Renieramycin M Attenuates Cancer Stem Cell-like Phenotypes in H460 Lung Cancer Cells.
    Anticancer Res. 2017;37:615-621.
    PubMed     Text format     Abstract available
    
    
    
31. TIAN J, Xiao H, Wu R, Cao Y, et al
    The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.
    Anticancer Res. 2017;37:547-553.
    PubMed     Text format     Abstract available
    
    
    January 2017
32. 
    Germline Stem Cells.
    Anticancer Res. 2017;37:368.
    PubMed     Text format    
    
    
    
33. 
    Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract.
    Anticancer Res. 2017;37:363-364.
    PubMed     Text format    
    
    
    
34. 
    Working with Stem Cells.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    
    
    
    
35. 
    Stem Cell Processing.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    
    
    
    
36. 
    Stem Cell Heterogeneity. Methods and Protocols.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    
    
    
    
37. 
    Cancer Stem Cells, 1st Edition. Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    
    
    
    
38. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    PubMed     Text format     Abstract available
    
    
    December 2016
39. TSAI PH, Cheng CH, Lin CY, Huang YT, et al
    Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
    Anticancer Res. 2016;36:6367-6380.
    PubMed     Text format     Abstract available
    
    
    
40. TAKEDA H, Okada M, Suzuki S, Kuramoto K, et al
    Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.
    Anticancer Res. 2016;36:6311-6318.
    PubMed     Text format     Abstract available
    
    
    November 2016
41. PIRES BR, DE Amorim IS, Souza LD, Rodrigues JA, et al
    Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Anticancer Res. 2016;36:5681-5691.
    PubMed     Text format     Abstract available
    
    
    
42. CHANVORACHOTE P, Chamni S, Ninsontia C, Phiboonchaiyanan PP, et al
    Potential Anti-metastasis Natural Compounds for Lung Cancer.
    Anticancer Res. 2016;36:5707-5717.
    PubMed     Text format     Abstract available
    
    
    October 2016
43. KARAS M, Steinerova K, Lysak D, Hrabetova M, et al
    Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.
    Anticancer Res. 2016;36:5487-5498.
    PubMed     Text format     Abstract available
    
    
    
44. SUZUKI S, Okada M, Kuramoto K, Takeda H, et al
    Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.
    Anticancer Res. 2016;36:5153-5161.
    PubMed     Text format     Abstract available
    
    
    
45. NAPOLETANO C, Bellati F, Ruscito I, Pernice M, et al
    Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells.
    Anticancer Res. 2016;36:5109-5116.
    PubMed     Text format     Abstract available
    
    
    August 2016
46. 
    Fetal Stem Cells in Regenerative Medicine. Principles and Translational Strategies.
    Anticancer Res. 2016;36:4374-5.
    PubMed     Text format    
    
    
    
47. 
    Mesenchymal Stem Cells. Methods and Protocols.
    Anticancer Res. 2016;36:4371.
    PubMed     Text format    
    
    
    
48. HOWARD CB, McDowell R, Feleke K, Deer E, et al
    Chemotherapeutic Vulnerability of Triple-negative Breast Cancer Cell-derived Tumors to Pretreatment with Vernonia amygdalina Aqueous Extracts.
    Anticancer Res. 2016;36:3933-43.
    PubMed     Text format     Abstract available
    
    
    July 2016
49. MUKOHYAMA J, Shimono Y, Yamashita K, Sumi Y, et al
    Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells.
    Anticancer Res. 2016;36:3679-86.
    PubMed     Text format     Abstract available
    
    
    
50. TASAKI T, Fujita M, Okuda T, Yoneshige A, et al
    MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.
    Anticancer Res. 2016;36:3571-7.
    PubMed     Text format     Abstract available
    
    
    
51. PYLVAS-EEROLA M, Liakka A, Puistola U, Koivunen J, et al
    Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer.
    Anticancer Res. 2016;36:3425-31.
    PubMed     Text format     Abstract available
    
    
    
52. SAKAUE M, Maeda K, Ohno S, Ito T, et al
    Screening for Identification of Personalized Food to Promote Adiponectin Secretion in Patients with Cancer.
    Anticancer Res. 2016;36:3673-7.
    PubMed     Text format     Abstract available
    
    
    February 2016
53. YOSHIYAMA A, Morii T, Ohtsuka K, Ohnishi H, et al
    Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
    Anticancer Res. 2016;36:625-31.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: